CN1124864C - 多源红外治疗仪 - Google Patents
多源红外治疗仪 Download PDFInfo
- Publication number
- CN1124864C CN1124864C CN 00112686 CN00112686A CN1124864C CN 1124864 C CN1124864 C CN 1124864C CN 00112686 CN00112686 CN 00112686 CN 00112686 A CN00112686 A CN 00112686A CN 1124864 C CN1124864 C CN 1124864C
- Authority
- CN
- China
- Prior art keywords
- oxide
- infrared
- source
- therapeutic apparatus
- radiation head
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 33
- 239000011248 coating agent Substances 0.000 claims abstract description 27
- 238000000576 coating method Methods 0.000 claims abstract description 27
- 239000000758 substrate Substances 0.000 claims abstract description 23
- 238000001228 spectrum Methods 0.000 claims abstract description 11
- 229910044991 metal oxide Inorganic materials 0.000 claims abstract description 7
- 150000004706 metal oxides Chemical class 0.000 claims abstract description 7
- 206010053615 Thermal burn Diseases 0.000 claims abstract description 5
- 230000005855 radiation Effects 0.000 claims description 67
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 20
- 230000007246 mechanism Effects 0.000 claims description 20
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 claims description 17
- 229910000423 chromium oxide Inorganic materials 0.000 claims description 17
- 238000009413 insulation Methods 0.000 claims description 11
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 10
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 10
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims description 10
- 239000011787 zinc oxide Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 229910000416 bismuth oxide Inorganic materials 0.000 claims description 8
- TYIXMATWDRGMPF-UHFFFAOYSA-N dibismuth;oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Bi+3].[Bi+3] TYIXMATWDRGMPF-UHFFFAOYSA-N 0.000 claims description 8
- 239000011159 matrix material Substances 0.000 claims description 8
- 229910052710 silicon Inorganic materials 0.000 claims description 6
- 238000000227 grinding Methods 0.000 claims description 5
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims description 5
- 235000019353 potassium silicate Nutrition 0.000 claims description 5
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical group [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 claims description 5
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 claims description 4
- 239000005751 Copper oxide Substances 0.000 claims description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 4
- 229910000431 copper oxide Inorganic materials 0.000 claims description 4
- 229910000480 nickel oxide Inorganic materials 0.000 claims description 4
- GNRSAWUEBMWBQH-UHFFFAOYSA-N oxonickel Chemical compound [Ni]=O GNRSAWUEBMWBQH-UHFFFAOYSA-N 0.000 claims description 4
- 239000010703 silicon Substances 0.000 claims description 4
- 239000011230 binding agent Substances 0.000 claims description 3
- 238000010276 construction Methods 0.000 claims description 3
- 238000005485 electric heating Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000000465 moulding Methods 0.000 claims description 3
- 238000005245 sintering Methods 0.000 claims description 3
- 229910052782 aluminium Inorganic materials 0.000 claims description 2
- 229910052796 boron Inorganic materials 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 239000010949 copper Substances 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 229910052748 manganese Inorganic materials 0.000 claims description 2
- 239000011572 manganese Substances 0.000 claims description 2
- 229910052759 nickel Inorganic materials 0.000 claims description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 229910052709 silver Inorganic materials 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 229910052719 titanium Inorganic materials 0.000 claims description 2
- 239000010936 titanium Substances 0.000 claims description 2
- 229910052721 tungsten Inorganic materials 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 24
- 238000010438 heat treatment Methods 0.000 abstract description 12
- 230000036541 health Effects 0.000 abstract description 4
- 238000002560 therapeutic procedure Methods 0.000 abstract description 4
- 230000005611 electricity Effects 0.000 abstract 1
- 230000003028 elevating effect Effects 0.000 abstract 1
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 abstract 1
- 230000001678 irradiating effect Effects 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 13
- 238000011282 treatment Methods 0.000 description 11
- 206010015037 epilepsy Diseases 0.000 description 10
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 238000011160 research Methods 0.000 description 5
- 230000006872 improvement Effects 0.000 description 4
- 238000000554 physical therapy Methods 0.000 description 4
- 238000001467 acupuncture Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002457 bidirectional effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000008336 microcirculatory blood flow Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- PCGVPMHGSJFFTI-ZEYGOCRCSA-N (4ar,5as,8ar,13as,15as,15br)-4a,5,5a,7,8,13a,15,15a,15b,16-decahydro-2h-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinoline-14-one;nitric acid Chemical compound O[N+]([O-])=O.O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 PCGVPMHGSJFFTI-ZEYGOCRCSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 206010008617 Cholecystitis chronic Diseases 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 208000032982 Hemorrhagic Fever with Renal Syndrome Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010033888 Paraphilia Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 230000005669 field effect Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000000712 neurohormone Substances 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 210000003446 pia mater Anatomy 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001543 purgative effect Effects 0.000 description 1
- 230000000191 radiation effect Effects 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 239000010944 silver (metal) Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 229940059935 strychnine nitrate Drugs 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Landscapes
- Radiation-Therapy Devices (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 00112686 CN1124864C (zh) | 2000-02-15 | 2000-02-15 | 多源红外治疗仪 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 00112686 CN1124864C (zh) | 2000-02-15 | 2000-02-15 | 多源红外治疗仪 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1308977A CN1308977A (zh) | 2001-08-22 |
CN1124864C true CN1124864C (zh) | 2003-10-22 |
Family
ID=4582527
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 00112686 Expired - Lifetime CN1124864C (zh) | 2000-02-15 | 2000-02-15 | 多源红外治疗仪 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1124864C (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1862628B (zh) * | 2006-06-19 | 2010-12-08 | 上海序参量科技发展有限公司 | 具有光浴功能的显示设备 |
CN101225096B (zh) * | 2008-01-23 | 2011-06-01 | 吉林省奇健生物技术有限公司 | 一种制备脱氧核苷酸的方法 |
CN103089029A (zh) * | 2011-11-03 | 2013-05-08 | 成都鑫博浩科技有限公司 | 改进的组合式可移动宽频谱能量辐射的保健屋 |
CN104177876A (zh) * | 2013-05-22 | 2014-12-03 | 中国科学院上海硅酸盐研究所 | 一种红外辐射涂料及其制备方法 |
CN105733327A (zh) * | 2015-12-24 | 2016-07-06 | 上海荣泰健康科技股份有限公司 | 一种红外涂层材料及其红外健身理疗器 |
CN106237541A (zh) * | 2016-09-14 | 2016-12-21 | 安徽瑞德医疗设备制造有限公司 | 一种具有回转调节功能的红外线治疗设备 |
CN107551407B (zh) * | 2017-09-22 | 2019-05-21 | 盛丽萍 | 一种高低位置可调节远红外线理疗仪 |
CN110518004B (zh) * | 2019-08-29 | 2021-10-01 | 合肥工业大学智能制造技术研究院 | 适于糖尿病性视网膜病变的专用光源及灯具 |
-
2000
- 2000-02-15 CN CN 00112686 patent/CN1124864C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1308977A (zh) | 2001-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1124864C (zh) | 多源红外治疗仪 | |
CN202665780U (zh) | 远红外led光子家用理疗热敷垫 | |
CN105561479B (zh) | 量子点应用于理疗、保健以及美容 | |
CN204723616U (zh) | 一种远红外线妇健温灸仪 | |
CN106113788A (zh) | 一种促进血液循环、新陈代谢和提高人体免疫力的硅胶理疗制品及其制造方法 | |
CN207445351U (zh) | 一种乳腺增生治疗仪 | |
CN2794544Y (zh) | 纳米硅碳复合纤维电热体疗仪 | |
CN107982642A (zh) | 一种理疗治疗器 | |
EP0291569B1 (en) | Method and apparatus for treatment by radiation matched with the human body's frequency spectrum | |
CN108686305A (zh) | 治疗仪 | |
CN1150041C (zh) | 多源红外能量治疗室 | |
CN201415004Y (zh) | 一种全身光照治疗装置 | |
CN211326697U (zh) | 一种多功能便携舒脊仪 | |
CN210131260U (zh) | 一种低强度激光修复全身光疗仪 | |
CN101524578A (zh) | 一种美容嫩肤仪 | |
CN201168347Y (zh) | 芯片集成led光子烧伤治疗装置 | |
CN2072845U (zh) | 一种便携式电磁波辐射治疗器 | |
CN1056820A (zh) | 宽频带频谱治疗仪及其制造方法 | |
CN209714005U (zh) | 特定电磁波、红外线二合一治疗器的治疗头 | |
CN1049605C (zh) | 保健治疗屋 | |
CN200957251Y (zh) | 宽频电磁波谱保健治疗器 | |
CN2675164Y (zh) | 光子痤疮治疗仪 | |
CN215132931U (zh) | 一种热磁波刮痧拔罐器 | |
CN216136580U (zh) | 一种多功能远红外理疗仓 | |
CN113769279B (zh) | 一种同光源宽光谱多波段多用途光谱辐照治疗仪 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: YING ZHAN Free format text: FORMER OWNER: XINGYUN INDUSTRY CO., LTD (CHENGDU) Effective date: 20080725 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20080725 Address after: High tech Zone of Chengdu City, Sichuan Province, Gaopeng Road No. 5 standard factory 21E1 Patentee after: Ying Zhan Address before: Sichuan province Chengdu City Shuncheng Street No. 262 north two floor (Youth Palace) Patentee before: Xingyun Industry Co., Ltd (Chengdu) |
|
CX01 | Expiry of patent term |
Granted publication date: 20031022 |
|
CX01 | Expiry of patent term |